| Literature DB >> 28572933 |
Phatcharaporn Budluang1, Pornsiri Pitchakarn1, Pisamai Ting2, Piya Temviriyanukul2, Ariyaphong Wongnoppawich1, Arisa Imsumran1.
Abstract
This study investigated biological activities including antioxidative stress, anti-inflammation, and anti-insulin resistance of Anoectochilus burmannicus aqueous extract (ABE). The results showed abilities of ABE to scavenging DPPH and ABTS free radicals in a dose-dependent manner. Besides, ABE significantly reduced nitric oxide (NO) production in the lipopolysaccharide (LPS)-treated RAW 264.7 via inhibition of mRNA and protein expressions of nitric oxide synthase (iNOS). The LPS-induced mRNA expressions of cyclooxygenase-2 (COX-2) and interleukin 1β (IL-1β) were suppressed by ABE. Moreover, ABE exerted anti-insulin resistance activity as it significantly improved the glucose uptake in tumor necrosis factor (TNF)-α treated 3T3-L1 adipocytes. In addition, ABE at the concentration of up to 200 μg/mL was not toxic to human peripheral blood mononuclear cells (PBMCs) and did not induce mutations. Finally, the results of our study suggest the potential use of A. burmannicus as anti-inflammatory, anti-insulin resistance agents, or food supplement for prevention of chronic diseases.Entities:
Keywords: 3T3‐L1 adipocyte; Anoectochilus burmannicus; RAW264.7 macrophage; inflammation; insulin resistance
Year: 2016 PMID: 28572933 PMCID: PMC5449198 DOI: 10.1002/fsn3.416
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Figure 1Free radical scavenging activity of ABE determined by DPPH (A) and ABTS (B) assays. Effect of ABE on cell viability of murine macrophage raw 264.7 cells (C), murine mature 3T3‐L1 adipocytes (D), and human PBMCs (E). ** p<0.01, *** p<0.001 vs. control (non‐treated group). ABE, Anoectochilus burmannicus aqueous extract
Effect of ABE on Drosophila genome
| Experiment | Treatment | Spot per wing (Number of spots from 40 wings) | ||||
|---|---|---|---|---|---|---|
| Sample | Concentration | Small single (m = 2) | Large single (m = 5) | Twin spot (m = 5) | Total spot (m = 2) | |
| 1 | Negative control | — | 0.30 (12) | 0.03 (1) | 0 (0) | 0.33 (13) |
| Urethane | 20 mmol/L | 8.10 (324)+ | 2.08 (83)+ | 1.10 (44)+ | 11.28 (451)+ | |
| ABE | 500 μg/ml | 0.20 (8)− | 0.08 (3)i | 0.05 (2)i | 0.33 (13)i | |
| 2 | Negative control | — | 0.43 (17) | 0.10 (4) | 0.03 (1) | 0.55 (22) |
| Urethane | 20 mmol/L | 18.85 (754)+ | 6.88 (275)+ | 3.03 (121)+ | 28.75 (1150)+ | |
| ABE | 500 μg/ml | 0.28 (11) − | 0.05 (2) − | 0.05 (2)i | 0.38 (15) − | |
Statistical diagnoses using estimation of spot frequencies and confidence limits according to Frei and Würgler (1988) for comparison with deionized water; +, Positive; −, Negative; i, Inconclusive.
Probability levels: α = β = 0.05. One‐sided statistical test “m” is an increased mutation frequency compared with the spontaneous frequency (m times). ABE, Anoectochilus burmannicus aqueous extract.
Figure 2Effects of ABE on nitric oxide (NO) production (A), on protein expression of tumor necrosis factor (TNF‐α), and inerleukin 6 (IL‐6) (B) and on mRNA expression of IL‐6, IL1‐β, and TNF‐α (C). ** p<0.01, *** p<0.001 vs. LPS‐treated group ABE, Anoectochilus burmannicus aqueous extract
Figure 3Effects of ABE on inducible nitric oxide synthase (iNOS) protein expression in LPS‐stimulated raw 264.7 cells (A) and on iNOS and COX‐2 mRNA expression (B). *** p<0.001 vs LPS‐treated group ABE, Anoectochilus burmannicus aqueous extract
Figure 4Anti‐insulin resistance activity of ABE in TNF‐α‐treated 3T3‐L1 adipocytes. * p<0.05, ** p<0.01 vs. TNF‐α‐treated group. ABE, Anoectochilus burmannicus aqueous extract